Apixio raised $13.5 million for its software and analytics business, which focuses on helping payers and providers estimate patient risk and costs.
Aver Informatics has raised $8.5 million for its software that helps create bundled payment systems.
Please, please stop funding these companies--you are wasting your time and money and I am tired of writing about them. Mango Health has raised $5.25 million for its app to help improve patients' adherence to treatment regimens.
http://www.pehub.com/2014/05/kpcb-leads-series-a-round-for-mango-health/Tennessee regulators are proposing that a patient who uses telemedicine first must have an in-person visit with the physician on the other end of the line. The purported reason is to ensure use of a primary care doctor and building a solid relationship, but the rule would greatly frustrate the ability of telemedicine to provide better and more convenient access to patients and would raise costs.
http://www.tennessean.com/story/money/industries/health-care/2014/05/19/tennessee-tighten-rules-telemedicine/9306711/SureScripts routed over a billion prescriptions last year, 58% of the total. Outstanding progress has been made in moving to eprescribing.
http://surescripts.com/news-center/press-releases/!content/surescripts-reports-more-than-half-of-all-prescriptions-routed-electronically-in-2013-driving-adoption-of-broader-health-information-exchangeFilament has received a seed round of $1 million for its digital personalized care plan offering.
http://medcitynews.com/2014/05/filament-labs-modernize-paper-based-care-plans/?utm_source=MedCity+News+Subscribers&utm_campaign=9b124f47c6-RSS_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_c05cce483a-9b124f47c6-67648197About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.